Download Volume 4, Supplement 1

Document related concepts

Pharmaceutical industry wikipedia , lookup

Prescription costs wikipedia , lookup

Discovery and development of neuraminidase inhibitors wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

CCR5 receptor antagonist wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Bad Pharma wikipedia , lookup

Theralizumab wikipedia , lookup

Bilastine wikipedia , lookup

Discovery and development of HIV-protease inhibitors wikipedia , lookup

Discovery and development of non-nucleoside reverse-transcriptase inhibitors wikipedia , lookup

Discovery and development of integrase inhibitors wikipedia , lookup

HIV vaccine wikipedia , lookup

Transcript
Abstract 01
Approaches towards HIV-1
Eradication: Harnessing Cellular
Restrictions
M Stevenson
University of Massachusetts Medical School, Worcester,
MA, USA
The replication of primate lentiviruses is dependent
upon their ability to commandeer cellular factors
at various stages in the replication cycle. Research
over the past several years however, has revealed
the presence of “cellular restrictions” that potently
antagonize viral replication. For example, the Apobec
3 proteins are cytidine deaminases that compromise
the formation and integrity of viral cDNA while Bst2/
tetherin prevents detachment of budding viruses
from the surface of the infected cell. In order to
counteract these restrictions, primate lentiviruses
have evolved accessory proteins: the Vif protein
targets Apobec 3 for proteasomal destruction while
Vpu mislocalizes Bst2/tetherin away from sites of
virus budding. We have recently obtained evidence
for a novel restriction that is expressed in cells
of macrophage lineage. This restriction potently
antagonizes the replication of primate lentiviruses
including HIV-1/2 and SIV as well as retroviruses
such as MLV. We have evidence that this restriction
is counteracted by the viral accessory proteins Vpx/
Vpr. These proteins commandeer a damaged DNA
response protein (DDB1) to target the restriction to
the proteasome. We have further obtained evidence
that this restriction dictates the cell cycle dependence
of lentivirus and retrovirus infection. Therefore when
the restriction is neutralized, macrophages, which are
normally refractory to MLV infection, are rendered
permissive to MLV transduction. With a view to
targeting accessory proteins for drug discovery, we
have identified small molecule inhibitors of HIV-1
Vif. These Vif antagonists exhibit antiviral effects only
in cells that express Apobec 3 proteins and increase
the extent of cytidine deamination in nascent viral
cDNA. Given our increasing understanding of the
HIV DART 2008 - Frontiers in Drug Development for Antiretroviral Therapies
function of the viral accessory proteins, they remain
highly attractive targets for therapeutic intervention
in HIV/AIDS.
Abstract 02
Understanding HIV Maturation
using Electron Cryotomography
ER Wright1, JB Schooler1, HJ Ding1, C Kieffer2,
C Fillmore2, WI Sundquist2, and GJ Jensen1
1 Division of Biology, California Institute of Technology,
Pasadena, CA, USA; 2 Department of Biochemistry,
University of Utah, Salt Lake City, UT, USA
BACKGROUND: HIV maturation is a dynamic process,
which occurs once the virus buds and is released from
the infected cell. The unprocessed Gag polyprotein
is composed of polypeptide segments, termed MA,
CA, SP1, NC, SP2, and p6 that are arranged radially,
with the N-terminal MA region at the membrane
and the C-terminal NC-SP2-p6 region nearest the
center [1, 2]. Maturation involves the proteolytic
processing of Gag and Gag-Pol polyproteins by
protease (PR). During maturation, MA remains
bound to the membrane, while the processed CA
subunits condense to form a central conical capsid
that encases NC, the RNA genome, and other viral
enzymes. The structures of nearly every component
of HIV have been determined, but it is still unclear
how individual subunits come together to form the
intact virion. We are studying the maturation process
of HIV-1 by electron cryotomography (cryo-ET) in
order to understand the structural changes that occur
within the virus.
METHODS: HIV-1 virions were made non-infectious
and/or halted in the immature state by the inactivation
of the proteins PR, RT, and RNase H [3, 4]. Solutions
of the purified HIV-1 virions were flash-frozen onto
EM grids in liquid ethane. The frozen-hydrated grids
were imaged in a 300 kV “G2 Polara” FEI TEM under
low dose conditions. Single and dual-axis tilt series
were collected using the predictive UCSF tomography
package [5]. All images were energy-filtered, recorded
3